Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

NCT05411887 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2845

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias
Hypertension

Interventions

DRUG: Rosuvastatin, Olmesartan Medoxomil

Sponsor

Daewoong Pharmaceutical Co. LTD.